Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,367,777 | 891,658 | 445,669 | 1,778,316 | 1,291,054 |
| Accounts payable and accrued liabilities | -1,143,699 | -779,464 | -389,505 | -1,386,382 | -1,030,153 |
| Other Working Capital | 128,205 | 59,187 | 22,492 | 315,714 | 209,732 |
| Other Operating Activity | -226,762 | -112,726 | -56,387 | -382,574 | -261,281 |
| Operating Cash Flow | $125,521 | $58,655 | $22,269 | $325,074 | $209,352 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,478 | -11,367 | 2,682 | -61,081 | -54,852 |
| PPE Investments | -55,757 | -35,555 | -16,125 | -66,795 | -48,931 |
| Net Acquisitions | -88,694 | -67,345 | -66,496 | -35,990 | -35,937 |
| Purchase Sale Intangibles | -2,715 | -2,031 | -1,681 | -9,566 | -7,430 |
| Other Investing Activity | -1,481 | 11,118 | 2,925 | -12,086 | -13,641 |
| Investing Cash Flow | $-164,410 | $-103,149 | $-77,014 | $-175,952 | $-153,361 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 2,000 | N/A | 294,750 | 294,750 |
| Debt Repayment | -5,441 | -2,940 | -1,595 | -6,823 | -5,253 |
| Common Stock Issued | 9,017 | 5,623 | 2,696 | 10,286 | 7,668 |
| Other Financing Activity | 1,647 | -492 | -68 | -4,280 | -4,902 |
| Financing Cash Flow | $7,223 | $4,191 | $1,033 | $293,933 | $292,263 |
| Exchange Rate Effect | 12,368 | 4,588 | 1,908 | 2,359 | 1,401 |
| Beginning Cash Position | 649,938 | 649,938 | 649,938 | 204,524 | 204,524 |
| End Cash Position | 630,640 | 614,223 | 598,134 | 649,938 | 554,179 |
| Net Cash Flow | $-19,298 | $-35,715 | $-51,804 | $445,414 | $349,655 |
| Free Cash Flow | |||||
| Operating Cash Flow | 125,521 | 58,655 | 22,269 | 325,074 | 209,352 |
| Capital Expenditure | -56,266 | -35,874 | -16,409 | -68,044 | -48,931 |
| Free Cash Flow | 69,255 | 22,781 | 5,860 | 257,030 | 160,421 |